Taken together, these data revealed that pancreatic cancer cells actively defend against gemcitabine stress by accelerating cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling. The gene discussed is EGFR; the disease is familial pancreatic carcinoma.